Transgene Biotek Ltd (526139) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 526139 | NSE: | Hospital & Healthcare Services | Small Cap

Transgene Biotek Share Price

2.86 0.02 0.70%
as on 16-Dec'25 16:59

DeciZen - make an informed investing decision on Transgene Biotek

Based on:

M-Cap below 100cr DeciZen not available

Transgene Biotek stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
21.5 Cr.
52-wk low:
2.6
52-wk high:
8

Is Transgene Biotek Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Transgene Biotek: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transgene Biotek Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -11.9%-17.1%-9.1%-21.4%-34.9%-49.1%-73.2%-57.5%-7.4%-6.1%-
Value Creation
Index
-1.9-2.2-1.7-2.5-3.5-4.5NANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.20.30.10.100.20.10.10.20.30
Sales YoY Gr.-55.6%-57.1%-41.7%-100%NA-47.1%-33.3%283.3%13%-
Adj EPS -2.8-2.6-1.1-1.3-1.5-1.4-1.4-0.8-0.1-0.1-0.2
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 20.45.54.63.420.6-0-0.8-0.9-1-1.1
Adj Net
Profit
-21.5-19.9-8.5-10-11-10.4-10.4-6-0.7-0.7-2
Cash Flow from Ops. 00-0.6-1.70.100.1001.2-
Debt/CF from Ops. 818692.9-15.8-5.374.1901.5122.9437333043.712.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.2%NA42.4%13%
Adj EPS NANANANA
BVPS-171.5%-187.1%NANA
Share Price 1.2% -10.1% -1% -60.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-12.9-20.3-22.2-33-53.3-105.6-465.8187.6109.420
Op. Profit
Mgn %
-623.1-910.9-1779.2-944.2-24147.1-307.2-531.8-1104.2-258.1-430.2-332.9
Net Profit
Mgn %
-11864.4-7071.7-7161.3-14076-306601.7-6153.4-11998.4-10901.5-279.1-259.3-612
Debt to
Equity
0.10.40.30.40.72.4-61-2.1-2-1.9-
Working Cap
Days
1,34,72954,93775,0861,21,12724,16,57851,1631,00,2341,58,61537,42333,676430
Cash Conv.
Cycle
18,1021,1321551723,53752234411-137-755-4,989

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Transgene Biotek Ltd.

Standalone Consolidated
TTM EPS (₹) -0.2 -0.2
TTM Sales (₹ Cr.) 0.3 0.3
BVPS (₹.) -1.1 1.2
Reserves (₹ Cr.) -84 -67
P/BV -2.57 2.34
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 2.61 / 8.00
All Time Low / High (₹) 0.10 / 322.50
Market Cap (₹ Cr.) 21.5
Equity (₹ Cr.) 75.8
Face Value (₹) 10
Industry PE 88.5

Management X-Ray of Transgene Biotek:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Transgene Biotek - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Transgene Biotek

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.180.280.120.0700.170.090.060.230.26
Operating Expenses 1.312.842.220.740.870.690.550.660.841.38
Manufacturing Costs0.150.130.070.100.200.020.010.0200
Material Costs000.050.030.010.06-0.050.0700
Employee Cost 0.390.270.200.250.290.250.290.300.310.31
Other Costs 0.782.441.900.370.360.370.290.270.531.07
Operating Profit -1.13-2.56-2.10-0.67-0.86-0.52-0.46-0.61-0.61-1.12
Operating Profit Margin (%) -623.0%-910.0%-1,779.3%-944.0%-24,147.1%-307.0%-531.0%-1,104.2%-258.0%-430.0%
Other Income 0.170.667.372.040.180.270.210.180.180.78
Interest 0.070.431.030.260.380.270.230.620.140.24
Depreciation 20.5017.539.899.899.909.919.924.950.090.09
Exceptional Items 0000000000
Profit Before Tax -21.54-19.86-5.65-8.79-10.96-10.43-10.40-6.01-0.66-0.68
Tax 000.790000000
Profit After Tax -21.54-19.86-6.44-8.79-10.96-10.43-10.40-6.01-0.66-0.68
PAT Margin (%) -11,864.4%-7,071.7%-5,445.3%-12,334.2%-3,06,601.7%-6,153.4%-11,998.4%-10,901.5%-279.0%-259.0%
Adjusted EPS (₹)-2.8-2.6-0.9-1.2-1.5-1.4-1.4-0.8-0.1-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 154.6641.2934.8526.0615.104.66-0.20-6.21-6.87-7.55
Share Capital 75.7775.7775.7775.7775.7775.7775.7775.7775.7775.77
Reserves 78.89-34.48-40.92-49.71-60.67-71.11-75.97-81.98-82.64-83.32
Minority Interest0000000000
Debt15.2814.769.859.1310.3311.3312.0213.121414.52
Long Term Debt6.345.193.844.104.284.544.774.955.086.10
Short Term Debt8.949.5765.046.056.797.258.178.928.42
Trade Payables0.840.540.550.290.380.240.200.230.201.59
Others Liabilities 122.3031.5831.4131.1831.0630.7625.2025.3325.1125.63
Total Liabilities 293.0988.1876.6666.6656.8646.9937.2232.4832.4434.20

Fixed Assets

Gross Block206.42107.86107.55107.58107.58107.61107.61107.61107.61109.31
Accumulated Depreciation65.4746.6956.5866.4876.3886.2896.21101.16101.25101.34
Net Fixed Assets 140.9561.1650.9741.1031.2021.3211.406.456.367.96
CWIP 0.292.041.871.871.871.871.871.871.871.87
Investments 92.2000000.010.110.110.100.10
Inventories0.070.070.040.030.040.020.090.030.030.03
Trade Receivables1.630.0100000000
Cash Equivalents 0.030.050.100.100.040.010.0200.010.28
Others Assets 57.9224.8523.6823.5623.7123.7623.7424.0224.0823.96
Total Assets 293.0988.1876.6666.6656.8646.9937.2232.4832.4434.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.020.02-0.63-1.740.140.010.10001.20
PBT -21.54-19.86-6.44-8.79-10.96-10.43-10.40-6.01-0.66-0.68
Adjustment 20.5819.245.068.2010.10109.984.960.050.16
Changes in Working Capital 0.980.650.75-1.1410.450.521.050.611.71
Tax Paid 0000000000
Cash Flow From Investing Activity -0.0203.051.740-0.04-0.10-0.010-1.70
Capex 003.371.740-0.030-00-1.70
Net Investments 0000000000
Others -0.020-0.3200-0.01-0.10-0.0100
Cash Flow From Financing Activity -0-0-2.370-0.2000000.78
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0-0-0.75000000-0.24
Dividend Paid 0000000000
Others 00-1.620-0.2000001.02
Net Cash Flow -00.020.05-0-0.06-0.020-0.0100.28

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-12.94-20.27-16.91-28.87-53.27-105.59N/AN/AN/AN/A
ROCE (%)-11.85-17.1-9.06-21.35-34.91-49.07N/AN/AN/AN/A
Asset Turnover Ratio000000000.010.01
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days01,06000000000
Inventory Days132851661873,549632424255348
Payable Days004,0794,5278,2701,858-1,7471,18800

Transgene Biotek Ltd Stock News

Transgene Biotek Ltd FAQs

The current trading price of Transgene Biotek on 16-Dec-2025 16:59 is ₹2.86.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Dec-2025 the market cap of Transgene Biotek stood at ₹21.52.
The latest P/E ratio of Transgene Biotek as of 15-Dec-2025 is 0.00.
The latest P/B ratio of Transgene Biotek as of 15-Dec-2025 is -2.57.
The 52-week high of Transgene Biotek is ₹8.00 and the 52-week low is ₹2.61.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transgene Biotek is ₹0.26 ( Cr.) .

About Transgene Biotek Ltd

Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies.

From the knowledge gained in developing recombinant vaccines successfully since 1994, and having gained considerable experience in improving the technology processes of those products, Transgene has expanded its product portfolio to other therapeutic areas such as Bio-generics, Oncology and New Drug Delivery Systems among others.

In line with its expanded product development portfolio, Transgene is modifying its existing infrastructure to cater to further Research & Development activities and is presently constructing a new manufacturing facility to meet WHO and US FDA standards.  Transgene is focused on maximizing synergies through strategic partnerships. We are excited to explore opportunities with partners and catalyze technological advances in the field of biotechnology.   Since 1994, Transgene Biotek has developed or has been involved in the development of technology for several different bio-pharmaceuticals, recombinant vaccines and therapeutics. We have extensive experience and expertise to assist you in recombinant drug development, characterization, testing and validation.

Product range of the company includes:

The company is engaged in manufacturing drugs for:

New Drug Delivery System (NDDS)

  • Oral Delivery of Insulin
  • Oral Delivery Hepatitis B Vaccine
  • Pegylation of Protein Drugs for Sustained Release

Biogeneries

  • Tacrolimus 
  • Pegylated EPO 

Human Vaccines

  • Meningococcal Meningitis
  • Universal Meningococcal Meningitis
  • Haemophilus Influenza B-Hib
  • DTP+Hib+Hep B Combination
  •  Hepatitis A+B Combination 

Cancer Drugs/Oncology

  • Multiple Myeloma
  • Barrett's Esophageal Cancer
  • Colon Cancer
  • Breast Cancer  

  

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×